Simplex Trading
CRNX icon

Simplex Trading’s Crinetics Pharmaceuticals CRNX Stock Holding History

Simplex Trading’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.92K Buy
+108
New +$4.82K ﹤0.01% 8040
2025
Q4 		– Sell
-1,944
Closed -$80K – 8787
2025
Q3 		$80K Sell
1,944
-3,397
-64% -$109K ﹤0.01% 5995
2025
Q2 		$153K Buy
5,341
+5,167
+2,970% +$160K ﹤0.01% 4786
2025
Q1 		$5K Sell
174
-86
-33% -$3.21K ﹤0.01% 7526
2024
Q4 		$13K Buy
+260
New +$14.5K ﹤0.01% 6995
2024
Q1 		– Sell
-23,534
Closed -$921K – 8981
2023
Q4 		$837K Sell
23,534
-86,842
-79% -$2.66M ﹤0.01% 3177
2023
Q3 		$3.28M Buy
110,376
+107,831
+4,237% +$2.22M ﹤0.01% 1643
2023
Q2 		$45K Buy
+2,545
New +$50.7K ﹤0.01% 5937
2022
Q3 		– Sell
-552
Closed -$11.3K – 10029
2022
Q2 		$10K Sell
552
-37,602
-99% -$750K ﹤0.01% 8271
2022
Q1 		$837K Buy
38,154
+17,874
+88% +$362K ﹤0.01% 3126
2021
Q4 		$576K Buy
+20,280
New +$500K ﹤0.01% 3608

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Simplex Trading's CRNX Position: Q1 2026 in Review

Simplex Trading opened a new position in Crinetics Pharmaceuticals (CRNX) in Q1 2026: 108 shares worth $3.92K. The stake represents ﹤0.01% of the portfolio and ranks #8040 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CRNX as recently as Q3 2025.

Simplex Trading first reported a position in CRNX in Q4 2021 and has held it in 11 quarters since. The position peaked at $3.28M in Q3 2023. 243 funds tracked by Wall St. Rank hold CRNX as of Q1 2026.

  • Simplex Trading held 108 shares of Crinetics Pharmaceuticals worth $3.92K as of Q1 2026.
  • Crinetics Pharmaceuticals was a new Simplex Trading position in Q1 2026.
  • Crinetics Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8040 holding.
  • Simplex Trading first reported a position in Crinetics Pharmaceuticals in Q4 2021 and has held it in 11 quarters since.
  • Simplex Trading's Crinetics Pharmaceuticals position peaked at $3.28M in Q3 2023.
  • 243 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.